CATX
Perspective Therapeutics Inc.
2.70$
-1.1%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2010 | 2010 | 2011 | 2011 | 2012 | 2012 | 2013 | 2013 | 2014 | 2014 | 2015 | 2015 | 2016 | 2016 | 2017 | 2017 | 2018 | 2018 | 2019 | 2019 | 2020 | 2020 | 2021 | 2021 | 2022 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -0.9% | +0.0% | -3.2% | +0.0% | -10.8% | +0.0% | -6.8% | +0.0% | +9.2% | +0.0% | +3.5% | +0.0% | -0.2% | +0.0% | +24.4% | +23.5% | +0.0% | +32.3% | +0.0% | +3.9% | +0.0% | +7.4% | +0.0% | -49.8% | +31.2% | -79.8% | +1.4% | -39.2% | |
| – | +0.0% | -10.5% | +0.0% | +7.0% | +0.0% | +0.2% | +0.0% | +0.9% | +0.0% | +0.5% | +0.0% | +4.5% | +0.0% | -15.5% | +0.0% | +4.0% | +4.6% | +0.0% | +6.8% | +0.0% | +8.3% | +0.0% | +25.3% | +0.0% | -50.7% | +79.5% | – | – | +41.0% | |
| – | +0.0% | +59.5% | +0.0% | -39.2% | +0.0% | -78.6% | +0.0% | -230.8% | – | – | +0.0% | -22.8% | +0.0% | +548.8% | +0.0% | +119.8% | +65.4% | +0.0% | +68.2% | +0.0% | -0.1% | +0.0% | -9.9% | +0.0% | -48.7% | -31.0% | -12.2% | -159.4% | – | |
| – | +0.0% | +36.5% | +0.0% | +57.0% | +0.0% | -14.2% | +0.0% | +6.6% | +0.0% | -8.1% | +0.0% | -14.1% | +0.0% | +82.7% | +0.0% | +80.9% | -15.6% | +0.0% | -23.6% | +0.0% | +26.7% | +0.0% | +80.9% | +0.0% | -29.8% | +43.5% | +719.0% | +84.6% | +114.1% | |
| – | +0.0% | -0.7% | +0.0% | -2.8% | +0.0% | -2.6% | +0.0% | +8.5% | +0.0% | -3.5% | +0.0% | +57.8% | +0.0% | +3.5% | +0.0% | +6.3% | +0.2% | +0.0% | +9.6% | +0.0% | +2.6% | +0.0% | +100.9% | -29.8% | +41.2% | +16.2% | +93.0% | +26.9% | +13.6% | |
| – | +0.0% | -13.0% | +0.0% | +4.4% | +0.0% | -1.9% | +0.0% | +4.1% | +0.0% | +2.5% | +0.0% | +15.7% | +0.0% | +37.1% | +0.0% | +20.0% | -2.9% | +0.0% | +3.3% | +0.0% | -0.5% | +0.0% | +112.5% | -34.0% | -4.5% | +51.9% | +143.2% | +55.6% | +72.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +495.3% | +0.0% | -71.5% | +0.0% | -100.0% | +0.0% | +12,514.3% | +0.0% | +150.7% | -9.7% | -52.5% | +5.3% | +14,400.0% | +0.0% | -80.0% | +0.0% | +362.1% | – | – | – | – | – | – | +0.0% | – | – | -42.9% | +683.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -584.0% | – | – | – | – | – | – | +0.0% | -147.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.